Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > The numbers don't tell the whole story...
View:
Post by wildbird1 on Mar 22, 2024 11:34am

The numbers don't tell the whole story...

On March 15, the SP was at 0.21$, as we speak the SP is at 0.175$.
A drop of 15% in the SP value.

TLT total shares count.
205 million shares.
68 million warrants.
14 million options.
Total 287 million.

During that 15% drop in SP value, if you consider that the same peoples that are selling could be buying back their own shares on the way down,you end up with less than 1/3 of 1% of the total shares count that were traded during that 15% drop in SP.

Where is the other 99.6% of TLT shares.....
Answer in the hands of strong believers.

Which indicate that except for a very few, nobody is panicking.
Comment by Alamir1111 on Mar 22, 2024 11:44am
Guess you're right 39million $market cap 287 millions of shares out 
Comment by Benedictus on Mar 23, 2024 7:17am
Current capital structure is on pg 22 of latest corp presentation. Fully diluted just shy of 345M. But certainly on track to see all those .35c wts expire as they incrementally get replaced by quarterly private placement warrants at far lower strikes. Recruitment rate is extremely concerning and Roger needs to address it in his next update. Why  have no patients been enrolled for almost 6 ...more  
Comment by Mikee3003 on Mar 22, 2024 11:48am
Panicking.....no Frustated.....extremely TLT ain't my first biotech rodeo, admittedly they have all had delays but TLT is in a class of its own!
Comment by O12009 on Mar 22, 2024 11:55am
As was Covid 19 that added years to the trial
Comment by Mikee3003 on Mar 22, 2024 1:03pm
The Covid delay card is getting old.....next excuse.....  "Ninety-nine percent of the failures come from people who have the habit of making excuses"  - George Washington
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250